James C. Fang

Active 1997–2025

Also published as
James C Fang
128
Papers
34,216
Citations
78
h-index
123
i10-index

Citations

Citations per year for James C. Fang1971: 1 citations1996: 2 citations1998: 2 citations1999: 2 citations2000: 11 citations2001: 8 citations2002: 18 citations2003: 40 citations2004: 49 citations2005: 57 citations2006: 47 citations2007: 46 citations2008: 49 citations2009: 47 citations2010: 44 citations2011: 58 citations2012: 92 citations2013: 133 citations2014: 163 citations2015: 199 citations2016: 174 citations2017: 206 citations2018: 180 citations2019: 642 citations2020: 759 citations2021: 858 citations2022: 839 citations2023: 1,073 citations2024: 1,993 citations2025: 1,016 citations2026: 29 citations1972–1995: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,736 citing papers, 23.4% of this breakdownUnited Kingdom: 1,128 citing papers, 7% of this breakdownItaly: 973 citing papers, 6.1% of this breakdownChina: 889 citing papers, 5.6% of this breakdownCanada: 793 citing papers, 5% of this breakdownGermany: 789 citing papers, 4.9% of this breakdownNetherlands: 613 citing papers, 3.8% of this breakdownFrance: 517 citing papers, 3.2% of this breakdownJapan: 491 citing papers, 3.1% of this breakdownSpain: 433 citing papers, 2.7% of this breakdownAustralia: 410 citing papers, 2.6% of this breakdownSweden: 377 citing papers, 2.3% of this breakdown
0%23.4%Other 30.3%

Fields

  • Medicine83.3%
  • Engineering6%
  • Biochemistry, Genetics and Molecular Biology6%
  • Immunology and Microbiology1.6%
  • Nursing0.5%
  • Computer Science0.5%
  • Other2.1%

Topics

  • Heart Failure Treatment and Management10.2%
  • Cardiovascular Function and Risk Factors8.8%
  • Diabetes Treatment and Management4.1%
  • Acute Myocardial Infarction Research4%
  • Mechanical Circulatory Support Devices3.6%
  • Cardiac Structural Anomalies and Repair2.7%
  • Other66.6%

Coauthors

All papers

Open in search
  1. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde - New England Journal of Medicine 2022 cited by 2,658

  2. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 2,590

  3. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 cited by 2,066

  4. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 881

  5. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2012 cited by 4,729

  6. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 cited by 361

  7. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Parkhomenko, Piotr Ponikowski, Félix José Alvarez Ramires, Pranas Šerpytis, Karen Sliwa, Jindřich Špinar, Thomas Suter, János Tomcsányi, Hans Vandekerckhove, Dragoş Vinereanu, Adriaan A. Voors, Mehmet Birhan Yılmaz, Faı̈ez Zannad, Lucie Sharpsten, Jason C. Legg, Claire Varin, Narimon Honarpour, Siddique Abbasi, Fady I. Malik, Christopher E. Kurtz - New England Journal of Medicine 2020 cited by 644

  8. Recognition and Initial Management of Fulminant Myocarditis

    Authors: , , , , , , , , , - Circulation 2020 cited by 596

  9. 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kim K. Birtcher, Joaquin E. Cigarroa, Lisa de las Fuentes, Anita Deswal, Dave L. Dixon, Lee A. Fleisher, Federico Gentile, Zachary D. Goldberger, Bülent Görenek, Norrisa Haynes, Adrian F. Hernandez, Mark A. Hlatky, José A. Joglar, W Schuyler Jones, Joseph E. Marine, Daniel B. Mark, Debabrata Mukherjee, Latha Palaniappan, Mariann R. Piano, Tanveer Rab, Erica S. Spatz, Jacqueline E. Tamis‐Holland, Duminda N. Wijeysundera, Y. Joseph Woo - Journal of Cardiac Failure 2022 cited by 406

  10. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , W.H. Wilson Tang, Yair Lev, Preethi William, Arthur L. Eberly, Stephen S. Gottleib, W. Herbert Haught, Gillian Grafton, Joshua Larned, Lokesh Tejwani, Freny Vaghaiwalla Mody, Selim R. Krim, Monique Robinson, James C. Fang, Alexander A. Adler, Adrian C. Bell, Dipanjan Banerjee, Ernesto A. Ruiz Duque, Ahmad Mizyed, John Rommel, Justice Arhinful, Parag Goyal, Michael E. Hall, Scott L. Hummel, Sanjay Shetty, Donald Haas, Juan Vilaro, Tamás Alexy, John M. Herre, J.M. Clark, Andrew P. Ambrosy, Nunzio Gaglianello, Kumudha Ramasubbu, Judith Meadows, Sara Tabtabai, Melody Sherwood, Syed Farhan Hasni, Michael D'Urso, Basharat Muneer, Stephanie H. Dunlap, William C. Davis, Dennis Friedman, Maya Guglin, Andrew D. Ferguson, Antonio Abbate, Frank W. Smart - JAMA 2023 cited by 181

  11. Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Cardiology 2022 cited by 122

  12. Heart Failure With Recovered Left Ventricular Ejection Fraction

    Authors: , , , - Journal of the American College of Cardiology 2020 cited by 314

  13. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , - Circulation 2022 cited by 317

  14. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Orly Vardeny, Subodh Verma, Pham Nguyễn Vinh, Ulrica Wilderäng, Natalia Zaozerska, Daniel Lindholm, Magnus Petersson, John J.V. McMurray - JACC Heart Failure 2022 cited by 165

  15. Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support

    Authors: , , , , , , , , , , , , , , , - Circulation 2019 cited by 213

  16. The Frailty Syndrome and Outcomes in the TOPCAT Trial

    Authors: , , , , , , , , , - European Journal of Heart Failure 2018 cited by 172

  17. Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 77

  18. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 67

  19. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , - JAMA 2019 cited by 320

  20. Heart Failure With Recovered Ejection Fraction

    Authors: , , , , , , , - Circulation 2014 cited by 312

  21. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , - Circulation Heart Failure 2016 cited by 324

  22. Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review

    Authors: , , - Journal of Cardiac Failure 2021 cited by 103

  23. Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes

    Authors: , , , , , , , - Circulation Heart Failure 2018 cited by 242

  24. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2012 cited by 2,248